CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's EPS Net Growth by Quarter and Year

Atara Biotherapeutics,'s EPS Net results by quarter and year




ATRA EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -1.74 -1.15 -0.63
III Quarter September - -1.29 -1.02 -0.88
II Quarter June -1.60 -1.15 -0.94 -0.66
I Quarter March -1.44 -1.05 -0.88 -0.58
FY   -3.04 -5.23 -3.99 -2.75



ATRA EPS Net second quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded EPS net loss of $ -1.60 .

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best EPS Net growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s EPS Net no change of % ranks overall at the positon no. in the second quarter.




ATRA EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2019 EPS Net $ -1.60 ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2018 EPS Net $ -1.15 Quarterly ATRA's Income Statement
New: More ATRA's historic EPS Net Growth >>


ATRA EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q EPS Net Comment
Current accomplishment of -1.60 by Atara Biotherapeutics, Inc. come out even worse considering the -1.44 a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q EPS Net Comment
II. Quarter 2019 results of -1.60 by Atara Biotherapeutics, Inc. appear even more unfavourable compare to the EPS net loss -1.44 in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative EPS Net 12 Months Ending $ -6.07 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -6 in the Jun 30 2019 period.
The business is detiriorating as the cumulative EPS net loss is becoming larger from $ -5.62 in the twelve months ending a quarter before and $ -1.44 for the twelve months ending in the quarter Isabel Hill told.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -6 in the Jun 30 2019 period.
The situation is worsening as the cumulative EPS net loss is inflating from $ -5.62 in TTM ending quarter and $ -1.44 for the twelve months ending in the quarter a year ago Isabel Hill told.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ATRA's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ATRA's Competitors
EPS Net Growth for Atara Biotherapeutics,'s Suppliers
EPS Net Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2019
Semler Scientific, Inc.  68.42 %$ 68.421 
Merck & Co., Inc.  63.49 %$ 63.492 
Medpace Holdings, inc.  62.22 %$ 62.222 
Iradimed Corporation  54.55 %$ 54.545 
Celgene Corp  51.05 %$ 51.049 
Biospecifics Technologies Corp  47.46 %$ 47.458 
Lhc Group, Inc  45.45 %$ 45.455 
Cellect Biotechnology Ltd.  45.00 %$ 45.000 
Align Technology inc  40.77 %$ 40.769 
Abbott Laboratories  36.59 %$ 36.585 
Nuvasive Inc  31.82 %$ 31.818 
Icon Plc  29.01 %$ 29.008 
Vertex Pharmaceuticals Inc  28.75 %$ 28.750 
Apollo Medical Holdings, Inc.  28.57 %$ 28.571 
Lifevantage Corp  27.00 %$ 26.996 
Ensign Group, Inc  24.39 %$ 24.390 
Penumbra Inc  24.32 %$ 24.324 
Intuitive Surgical, Inc.  24.19 %$ 24.186 
Corcept Therapeutics Inc  21.43 %$ 21.429 
Steris Plc  20.73 %$ 20.732 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CIRT's Profile

Stock Price

CIRT's Financials

Business Description

Fundamentals

Charts & Quotes

CIRT's News

Suppliers

CIRT's Competitors

Customers & Markets

Economic Indicators

CIRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071